Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
about
The pharmacogenetics of β-adrenergic receptor antagonists in the treatment of hypertension and heart failure.Cardiovascular pharmacogenomics: expectations and practical benefits.Understanding the Importance of Race/Ethnicity in the Care of the Hypertensive Patient.Contextualizing Genetics for Regional Heart Failure Care
P2860
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@ast
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@en
type
label
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@ast
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@en
prefLabel
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@ast
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@en
P2093
P2860
P356
P1476
Bucindolol: a pharmacogenomic perspective on its use in chronic heart failure
@en
P2093
David J Holland
Francesco Giallauria
Neil A Smart
Nigel Kwok
Rohan Jayasighe
P2860
P356
10.4137/CMC.S4309
P577
2011-06-28T00:00:00Z